We present the clinical case of a 76-year-old male with the following medical history: Active smoker (2 packs/day),moderate obesity, moderate COPD. arterial hypertension, mellitus diabetes 2, dyslipidemia. Lacunar stroke without neurological damage, infrarenal abdominal aortic aneurysm of 40 mm, under follow-up in policlinic of Vascular Surgery, 1st degree atrioventricular block, under follow-up by Cardiology. Normal Echocardiography. PET-CT: Hypermetabolic pulmonary nodule in RUL, suggestive of cancer. FUNCTIONAL TESTS: Moderate obstructive pattern. FEV1 2.20 (72%), FEV1/FVC 58. DLCO 5.80 (64%). AIRWAY EXPLORATION: Retrognatia, Mallampati III, significant cervical stiffness, thick neck and degree of movement of head and neck < 80°. Case Management: Placement of thoracic epidural catheter (T5-T6) prior to induction for analgesic control during intraoperative and postoperativeperiod. Non-invasive blood pressure monitoring, 5-lead ECG, temperature, peripheral oxygen saturation (SpO2), Bispectral Index (BIS) and Train-of-four (TOF). In the presence of predictors of possible difficult airway and ventilation, material is prepared for management of possible difficult airway Pre-oxygenation with face mask and FiO2 1 until EtO2 85 mmHg is reached. Rapid sequence induction was performed with intravenous midazolam, fentanyl, propofol and 1,2 mg/kg of rocuronium. After reaching TOF 0, direct laryngoscopy was initially performed but a Cormark-Lehane (CL) III was observed.Indirect laryngoscopy was then performed with a McGrath video laryngoscope with a n°4 disposable blade, showing a CL I. Subsequently, an 11 Fr airway exchange catheter was introduced through the vocal cords into the trachea; then, the proximal end of the airway exchange catheter was inserted into the endobronchial lumen of the 37Fr Vivasight DL, to permet its insertion into the trachea guided by this airway exchange catheter under the vision of the McGrath videolaryngoscope. Once the VivaSight DL was inserted into the trachea, the airway exchange catheter was removed and the VivaSight DL tube was turned left 90° and was inserted successful into the left main bronchus guided by embedded camera of this special type of DLT. Anesthesia maintenance was performed with inhalated sevoflurane and continuous intravenous infusion of remifentanil and rocuronium. Epidural elastomer of levobupivacaine 0.125% at 7 ml/h. Controlled ventilation is maintained in volume control mode, with Tidal Volume (TV) at 7 ml/kg ideal weight in two-lung ventilation and 5 ml/kg ideal weight in one-lung ventilation. Alveolar Recruitment Maneouvres (ARM) after intubation and at start of one-lung ventilation (OLV) were performed. Good mechanics and adequate gas exchange throughout the procedure, with no episodes of desaturation. After completion of surgery, reversal of neuromuscular blockade was achieved with sugammadex at 2 mg/kg. After checking TOF ratio> 90% and adequate level of consciousness, optimal respiratory mechanics and a 100% SpO2, extubation was performed without incident. He was transferred to the intensive care unit for post-surgical control during the first 24 hours.